Literature DB >> 8157929

Application of electron microscopic immunocytochemistry to the human kidney: distribution of type IV and type VI collagen in normal human kidney.

D Zhu1, Y Kim, M W Steffes, T J Groppoli, R J Butkowski, S M Mauer.   

Abstract

We used immunogold electron microscopic (IEM) techniques with periodate-lysine-paraformaldehyde-fixed and Lowicryl-embedded or cryopreserved tissues to study the distribution of alpha 1(IV) and alpha 3(IV) chains of Types IV and VI collagen in glomerular basement membrane (GBM) and mesangial matrix of glomeruli in normal human kidneys. Monoclonal antibodies to alpha 1(IV) and alpha 3(IV) collagen chains and Type VI collagen could be detected only with cryoultramicrotomy, whereas polyclonal anti-Type IV collagen antibody was detectable in Lowicryl-embedded tissue. Ultrastructural detail was better preserved in the Lowicryl-embedded tissue. IEM labeling provided more detailed information as to the site-specific array of these extracellular matrix molecules in glomeruli than did immunofluorescent microscopy. The labeling of alpha 1(IV) collagen chain was distributed mainly along the endothelial side of glomerular basement membrane and the mesangial matrix. Mesangial GBM was relatively poorly labeled compared with that of mesangial matrix. In contrast, the alpha 3(IV) chain was detected throughout the thickness of the GBM, but there was no labeling of mesangial matrix. Type VI collagen distribution was identical to that of the alpha 1(IV) chain within the glomerulus but was also associated with interstitial collagen fibrils. This study documents and details the heterogeneous distribution of Type IV and VI collagen chains within the normal human glomerulus and provides the framework for the study of these matrix components in human glomerular diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157929     DOI: 10.1177/42.5.8157929

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  7 in total

1.  Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat.

Authors:  Simone A Joosten; Mieneke G A van Dixhoorn; Maria C Borrias; Hallgrimur Benediktsson; Peter A van Veelen; Cees van Kooten; Leendert C Paul
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

2.  Immunohistochemical distribution of type VI collagen in developing human kidney.

Authors:  G Magro; S Grasso; A Colombatti; M Lopes
Journal:  Histochem J       Date:  1996-05

3.  Alterations of glomerular basement membrane charge and structure in diabetic nephropathy.

Authors:  N P Goode; M Shires; D M Crellin; S R Aparicio; A M Davison
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

Review 4.  Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function.

Authors:  Brittany Law; Vennece Fowlkes; Jack G Goldsmith; Wayne Carver; Edie C Goldsmith
Journal:  Microsc Microanal       Date:  2012-01-05       Impact factor: 4.127

5.  Compositional differences between infant and adult human corneal basement membranes.

Authors:  Andrea Kabosova; Dimitri T Azar; Gregory A Bannikov; Kevin P Campbell; Madeleine Durbeej; Reza F Ghohestani; Jonathan C R Jones; M Cristina Kenney; Manuel Koch; Yoshifumi Ninomiya; Bruce L Patton; Mats Paulsson; Yoshikazu Sado; E Helene Sage; Takako Sasaki; Lydia M Sorokin; Marie-France Steiner-Champliaud; Tung-Tien Sun; Nirmala Sundarraj; Rupert Timpl; Ismo Virtanen; Alexander V Ljubimov
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-11       Impact factor: 4.799

Review 6.  Biochemical composition of the glomerular extracellular matrix in patients with diabetic kidney disease.

Authors:  María M Adeva-Andany; Natalia Carneiro-Freire
Journal:  World J Diabetes       Date:  2022-07-15

7.  The Ultrastructural Localization of Type II, IV, and VI Collagens at the Vitreoretinal Interface.

Authors:  Shao Chong Bu; Roel Kuijer; Roelofje J van der Worp; Xiao Rong Li; Johanna M M Hooymans; Leonoor I Los
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.